1. [Comparative assessment of antiaggregant efficacy of acetylsalicylic acid and clopidogrel in peripheral atherosclerosis]
- Author
-
M R, Kuznetsov, N A, Sergeeva, V M, Koshkin, B V, Boldin, S V, Rodionov, A O, Virganskiĭ, I V, Kosykh, O P, Lisenkov, and V F, Kuznetsova
- Subjects
Male ,Ticlopidine ,Aspirin ,Platelet Aggregation ,Patient Selection ,Middle Aged ,Severity of Illness Index ,Clopidogrel ,Peripheral Arterial Disease ,Treatment Outcome ,Lower Extremity ,Therapeutic Equivalency ,Humans ,Female ,Platelet Aggregation Inhibitors ,Aged - Abstract
Presented in the article are the results of studying antiaggregate activity of acetylsalicylic acid and clopidogrel in a total of 36 patients suffering from various-severity chronic arterial insufficiency of lower limbs on the background of atherosclerosis obliterans. The study was conducted prior to treatment for correct selection of a particular antiplatelet agent. The obtained results showed that clopidogrel was not always more efficient than acetylsalicylic acid, since there is individual sensitivity of each patients to a particular antiplatelet agent. Therefore, an individual approach is necessary to conservative therapy of arterial insufficiency of lower limbs. For some patients it is preferable to administer clopidogrel, for others - acetylsalicylic acid. In a series of cases combined treatment is justified, while some patients having low sensitivity to both acetylsalicylic acid and clopidogrel require careful selection of alternative agents influencing other thrombocyte receptors.
- Published
- 2014